In vivo imaging of prostate tumors (xenografts and tibial implants) using QDs conjugated to PSMA, folate, and other ligands. Biodistribution, fluorescence tracking, and targeting specificity are confirmed. Here, FOLH1 is linked to prostate neoplasm.